Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The neurofibromatosis type 1 (NF1) gene has 61 exons. The major alternative exon in NF1 pre-mRNA is exon 23a. Skipping and inclusion of this exon produce isoform I and isoform II neurofibromin, respectively. When the alternative exon was discovered in 1993, several experiments conducted in yeast and human cell lines quickly led to the conclusion that inclusion of this exon reduced the RasGAP function of the neurofibromin protein by 5-10-fold. Since then, research efforts on this seemingly important alternative splicing event have been sporadic, leaving many important questions unanswered, until after 2020 when several important papers related to the structure and function of exon 23a have been published. Two major advancements have been made. First, the cryo-EM structures of the full-length neurofibromin, of both isoforms, have been solved. More excitingly, the structure of isoform II neurofibromin that includes exon 23a provides important insight into why this isoform has reduced RasGAP activity. Second, the role of the altered splicing pattern of exon 23a in the development of high-grade glioma (HGG) has been investigated. In this review, we start with the introduction of alternative splicing of exon 23a, its discovery, differential expression patterns, and regulatory mechanisms that control this alternative splicing event. Next, we discuss the structural differences between the two isoforms which give insight into the differing RasGAP activities. We then review the in vivo biological function of the regulated inclusion of exon 23a, focusing on cognitive behaviors and brain tumor development. Finally, we briefly discuss the future directions of studies on NF1 exon 23a. This article is categorized under: RNA Processing > Splicing Regulation/Alternative Splicing.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352984PMC
http://dx.doi.org/10.1002/wrna.70021DOI Listing

Publication Analysis

Top Keywords

exon 23a
32
alternative splicing
16
exon
12
inclusion exon
12
splicing exon
8
23a
8
neurofibromatosis type
8
structure function
8
function neurofibromin
8
alternative exon
8

Similar Publications

The neurofibromatosis type 1 (NF1) gene has 61 exons. The major alternative exon in NF1 pre-mRNA is exon 23a. Skipping and inclusion of this exon produce isoform I and isoform II neurofibromin, respectively.

View Article and Find Full Text PDF

Changes in protein levels of the mammalian cleavage factor, CFIm25, play a role in regulating pathological processes including neural dysfunction, fibrosis, and tumorigenesis. However, despite these effects, little is known about how CFIm25 (NUDT21) expression is regulated at the RNA level. A potential regulator of NUDT21 mRNA are small non-coding microRNAs (miRNAs).

View Article and Find Full Text PDF
Article Synopsis
  • Pre-mRNA splicing involves two key steps: 5' splice site cleavage and the ligation of exons, influenced by specific proteins called first and second step factors.
  • Researchers identified Fyv6 (FAM192A in humans) as a second step factor affecting splicing, and their RNA sequencing analysis revealed that its loss activates non-consensus splice sites across the transcriptome.
  • High-resolution cryo-electron microscopy showed that Fyv6 interacts uniquely with the Prp22 ATPase and its binding excludes another factor (Yju2), leading to a proposed model where Fyv6 enhances the use of traditional splice sites and aids in exon ligation.
View Article and Find Full Text PDF

Pre-mRNA splicing is catalyzed in two steps: 5' splice site (SS) cleavage and exon ligation. A number of proteins transiently associate with spliceosomes to specifically impact these steps (1 and 2 step factors). We recently identified Fyv6 (FAM192A in humans) as a 2 step factor in ; however, we did not determine how widespread Fyv6's impact is on the transcriptome.

View Article and Find Full Text PDF

Deficiency of the Heterogeneous Nuclear Ribonucleoprotein U locus leads to delayed hindbrain neurogenesis.

Biol Open

October 2023

Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute, Region Stockholm, 17164 Stockholm, Sweden.

Article Synopsis
  • Genetic changes affecting a protein called HNRNPU are found in several brain disorders in kids.
  • HNRNPU is important for the brain's growth, especially in the part called the cerebellum, but we don’t know how it affects this area yet.
  • Researchers found that when HNRNPU is missing, it changes how brain cells develop, which might connect to issues like epilepsy, autism, and learning challenges.
View Article and Find Full Text PDF